Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Mineralys Therapeutics Inc (NASDAQ: MLYS) closed at $14.16 in the last session, down -5.28% from day before closing price of $14.95. In other words, the price has decreased by -$5.28 from its previous closing price. On the day, 0.66 million shares were traded. MLYS stock price reached its highest trading level at $14.99 during the session, while it also had its lowest trading level at $13.8.
Ratios:
We take a closer look at MLYS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.20 and its Current Ratio is at 11.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 10, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.
On March 07, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $27.Wells Fargo initiated its Overweight rating on March 07, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 06 ’24 when Rodman David Malcom bought 25,482 shares for $15.03 per share.
Levy Adam Scott sold 10,757 shares of MLYS for $146,004 on Oct 11 ’24. The CFO and Secretary now owns 236,854 shares after completing the transaction at $13.57 per share. On Oct 11 ’24, another insider, Congleton Jon, who serves as the Chief Executive Officer of the company, sold 15,271 shares for $13.52 each. As a result, the insider received 206,433 and left with 895,941 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLYS now has a Market Capitalization of 743414144 and an Enterprise Value of 393014720.
Stock Price History:
Over the past 52 weeks, MLYS has reached a high of $16.91, while it has fallen to a 52-week low of $5.85. The 50-Day Moving Average of the stock is 10.04%, while the 200-Day Moving Average is calculated to be 10.58%.
Shares Statistics:
According to the various share statistics, MLYS traded on average about 158.88K shares per day over the past 3-months and 207850 shares per day over the past 10 days. A total of 41.13M shares are outstanding, with a floating share count of 22.48M. Insiders hold about 54.80% of the company’s shares, while institutions hold 45.89% stake in the company. Shares short for MLYS as of 1728950400 were 1613175 with a Short Ratio of 10.15, compared to 1726185600 on 1472177. Therefore, it implies a Short% of Shares Outstanding of 1613175 and a Short% of Float of 4.75.
